Global Equine Drugs and Supplement Market Growth 2026-2032
The global Equine Drugs and Supplement market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Equine Drugs and Supplement Industry Forecast? looks at past sales and reviews total world Equine Drugs and Supplement sales in 2025, providing a comprehensive analysis by region and market sector of projected Equine Drugs and Supplement sales for 2026 through 2032. With Equine Drugs and Supplement sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Drugs and Supplement industry.
This Insight Report provides a comprehensive analysis of the global Equine Drugs and Supplement landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Drugs and Supplement portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Equine Drugs and Supplement market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Drugs and Supplement and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Drugs and Supplement.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Drugs and Supplement market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Equine Drugs and Supplement Industry Forecast? looks at past sales and reviews total world Equine Drugs and Supplement sales in 2025, providing a comprehensive analysis by region and market sector of projected Equine Drugs and Supplement sales for 2026 through 2032. With Equine Drugs and Supplement sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Drugs and Supplement industry.
This Insight Report provides a comprehensive analysis of the global Equine Drugs and Supplement landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Drugs and Supplement portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Equine Drugs and Supplement market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Drugs and Supplement and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Drugs and Supplement.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Drugs and Supplement market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Supplements
- Pharmaceutical Drugs
- Drugstores
- Veterinary Hospitals
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer Animal Health
- Boehringer Ingelheim
- Elanco (Eli Lilly)
- Merck Animal Health
- Merial
- Novartis Animal Health
- Zoetis
- What is the 10-year outlook for the global Equine Drugs and Supplement market?
- What factors are driving Equine Drugs and Supplement market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Equine Drugs and Supplement market opportunities vary by end market size?
- How does Equine Drugs and Supplement break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Drugs and Supplement Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Equine Drugs and Supplement by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Equine Drugs and Supplement by Country/Region, 2021, 2025 & 2032
2.2 Equine Drugs and Supplement Segment by Type
2.2.1 Supplements
2.2.2 Pharmaceutical Drugs
2.2.3 Equine Drugs and Supplement Sales by Type
2.2.3.1 Global Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
2.2.3.2 Global Equine Drugs and Supplement Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Equine Drugs and Supplement Sale Price by Type (2021-2026)
2.3 Equine Drugs and Supplement Segment by Application
2.3.1 Drugstores
2.3.2 Veterinary Hospitals
2.3.3 Others
2.3.4 Equine Drugs and Supplement Sales by Application
2.3.4.1 Global Equine Drugs and Supplement Sale Market Share by Application (2021-2026)
2.3.4.2 Global Equine Drugs and Supplement Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Equine Drugs and Supplement Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Equine Drugs and Supplement Breakdown Data by Company
3.1.1 Global Equine Drugs and Supplement Annual Sales by Company (2021-2026)
3.1.2 Global Equine Drugs and Supplement Sales Market Share by Company (2021-2026)
3.2 Global Equine Drugs and Supplement Annual Revenue by Company (2021-2026)
3.2.1 Global Equine Drugs and Supplement Revenue by Company (2021-2026)
3.2.2 Global Equine Drugs and Supplement Revenue Market Share by Company (2021-2026)
3.3 Global Equine Drugs and Supplement Sale Price by Company
3.4 Key Manufacturers Equine Drugs and Supplement Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Drugs and Supplement Product Location Distribution
3.4.2 Players Equine Drugs and Supplement Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EQUINE DRUGS AND SUPPLEMENT BY GEOGRAPHIC REGION
4.1 World Historic Equine Drugs and Supplement Market Size by Geographic Region (2021-2026)
4.1.1 Global Equine Drugs and Supplement Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Equine Drugs and Supplement Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Equine Drugs and Supplement Market Size by Country/Region (2021-2026)
4.2.1 Global Equine Drugs and Supplement Annual Sales by Country/Region (2021-2026)
4.2.2 Global Equine Drugs and Supplement Annual Revenue by Country/Region (2021-2026)
4.3 Americas Equine Drugs and Supplement Sales Growth
4.4 APAC Equine Drugs and Supplement Sales Growth
4.5 Europe Equine Drugs and Supplement Sales Growth
4.6 Middle East & Africa Equine Drugs and Supplement Sales Growth
5 AMERICAS
5.1 Americas Equine Drugs and Supplement Sales by Country
5.1.1 Americas Equine Drugs and Supplement Sales by Country (2021-2026)
5.1.2 Americas Equine Drugs and Supplement Revenue by Country (2021-2026)
5.2 Americas Equine Drugs and Supplement Sales by Type (2021-2026)
5.3 Americas Equine Drugs and Supplement Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Drugs and Supplement Sales by Region
6.1.1 APAC Equine Drugs and Supplement Sales by Region (2021-2026)
6.1.2 APAC Equine Drugs and Supplement Revenue by Region (2021-2026)
6.2 APAC Equine Drugs and Supplement Sales by Type (2021-2026)
6.3 APAC Equine Drugs and Supplement Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Drugs and Supplement by Country
7.1.1 Europe Equine Drugs and Supplement Sales by Country (2021-2026)
7.1.2 Europe Equine Drugs and Supplement Revenue by Country (2021-2026)
7.2 Europe Equine Drugs and Supplement Sales by Type (2021-2026)
7.3 Europe Equine Drugs and Supplement Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Drugs and Supplement by Country
8.1.1 Middle East & Africa Equine Drugs and Supplement Sales by Country (2021-2026)
8.1.2 Middle East & Africa Equine Drugs and Supplement Revenue by Country (2021-2026)
8.2 Middle East & Africa Equine Drugs and Supplement Sales by Type (2021-2026)
8.3 Middle East & Africa Equine Drugs and Supplement Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Drugs and Supplement
10.3 Manufacturing Process Analysis of Equine Drugs and Supplement
10.4 Industry Chain Structure of Equine Drugs and Supplement
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Drugs and Supplement Distributors
11.3 Equine Drugs and Supplement Customer
12 WORLD FORECAST REVIEW FOR EQUINE DRUGS AND SUPPLEMENT BY GEOGRAPHIC REGION
12.1 Global Equine Drugs and Supplement Market Size Forecast by Region
12.1.1 Global Equine Drugs and Supplement Forecast by Region (2027-2032)
12.1.2 Global Equine Drugs and Supplement Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Equine Drugs and Supplement Forecast by Type (2027-2032)
12.7 Global Equine Drugs and Supplement Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer Animal Health
13.1.1 Bayer Animal Health Company Information
13.1.2 Bayer Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
13.1.3 Bayer Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer Animal Health Main Business Overview
13.1.5 Bayer Animal Health Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Equine Drugs and Supplement Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Elanco (Eli Lilly)
13.3.1 Elanco (Eli Lilly) Company Information
13.3.2 Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolios and Specifications
13.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Elanco (Eli Lilly) Main Business Overview
13.3.5 Elanco (Eli Lilly) Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
13.4.3 Merck Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Merial
13.5.1 Merial Company Information
13.5.2 Merial Equine Drugs and Supplement Product Portfolios and Specifications
13.5.3 Merial Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Merial Main Business Overview
13.5.5 Merial Latest Developments
13.6 Novartis Animal Health
13.6.1 Novartis Animal Health Company Information
13.6.2 Novartis Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
13.6.3 Novartis Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novartis Animal Health Main Business Overview
13.6.5 Novartis Animal Health Latest Developments
13.7 Zoetis
13.7.1 Zoetis Company Information
13.7.2 Zoetis Equine Drugs and Supplement Product Portfolios and Specifications
13.7.3 Zoetis Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zoetis Main Business Overview
13.7.5 Zoetis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Drugs and Supplement Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Equine Drugs and Supplement by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Equine Drugs and Supplement by Country/Region, 2021, 2025 & 2032
2.2 Equine Drugs and Supplement Segment by Type
2.2.1 Supplements
2.2.2 Pharmaceutical Drugs
2.2.3 Equine Drugs and Supplement Sales by Type
2.2.3.1 Global Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
2.2.3.2 Global Equine Drugs and Supplement Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Equine Drugs and Supplement Sale Price by Type (2021-2026)
2.3 Equine Drugs and Supplement Segment by Application
2.3.1 Drugstores
2.3.2 Veterinary Hospitals
2.3.3 Others
2.3.4 Equine Drugs and Supplement Sales by Application
2.3.4.1 Global Equine Drugs and Supplement Sale Market Share by Application (2021-2026)
2.3.4.2 Global Equine Drugs and Supplement Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Equine Drugs and Supplement Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Equine Drugs and Supplement Breakdown Data by Company
3.1.1 Global Equine Drugs and Supplement Annual Sales by Company (2021-2026)
3.1.2 Global Equine Drugs and Supplement Sales Market Share by Company (2021-2026)
3.2 Global Equine Drugs and Supplement Annual Revenue by Company (2021-2026)
3.2.1 Global Equine Drugs and Supplement Revenue by Company (2021-2026)
3.2.2 Global Equine Drugs and Supplement Revenue Market Share by Company (2021-2026)
3.3 Global Equine Drugs and Supplement Sale Price by Company
3.4 Key Manufacturers Equine Drugs and Supplement Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Drugs and Supplement Product Location Distribution
3.4.2 Players Equine Drugs and Supplement Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EQUINE DRUGS AND SUPPLEMENT BY GEOGRAPHIC REGION
4.1 World Historic Equine Drugs and Supplement Market Size by Geographic Region (2021-2026)
4.1.1 Global Equine Drugs and Supplement Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Equine Drugs and Supplement Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Equine Drugs and Supplement Market Size by Country/Region (2021-2026)
4.2.1 Global Equine Drugs and Supplement Annual Sales by Country/Region (2021-2026)
4.2.2 Global Equine Drugs and Supplement Annual Revenue by Country/Region (2021-2026)
4.3 Americas Equine Drugs and Supplement Sales Growth
4.4 APAC Equine Drugs and Supplement Sales Growth
4.5 Europe Equine Drugs and Supplement Sales Growth
4.6 Middle East & Africa Equine Drugs and Supplement Sales Growth
5 AMERICAS
5.1 Americas Equine Drugs and Supplement Sales by Country
5.1.1 Americas Equine Drugs and Supplement Sales by Country (2021-2026)
5.1.2 Americas Equine Drugs and Supplement Revenue by Country (2021-2026)
5.2 Americas Equine Drugs and Supplement Sales by Type (2021-2026)
5.3 Americas Equine Drugs and Supplement Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Drugs and Supplement Sales by Region
6.1.1 APAC Equine Drugs and Supplement Sales by Region (2021-2026)
6.1.2 APAC Equine Drugs and Supplement Revenue by Region (2021-2026)
6.2 APAC Equine Drugs and Supplement Sales by Type (2021-2026)
6.3 APAC Equine Drugs and Supplement Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Drugs and Supplement by Country
7.1.1 Europe Equine Drugs and Supplement Sales by Country (2021-2026)
7.1.2 Europe Equine Drugs and Supplement Revenue by Country (2021-2026)
7.2 Europe Equine Drugs and Supplement Sales by Type (2021-2026)
7.3 Europe Equine Drugs and Supplement Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Drugs and Supplement by Country
8.1.1 Middle East & Africa Equine Drugs and Supplement Sales by Country (2021-2026)
8.1.2 Middle East & Africa Equine Drugs and Supplement Revenue by Country (2021-2026)
8.2 Middle East & Africa Equine Drugs and Supplement Sales by Type (2021-2026)
8.3 Middle East & Africa Equine Drugs and Supplement Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Drugs and Supplement
10.3 Manufacturing Process Analysis of Equine Drugs and Supplement
10.4 Industry Chain Structure of Equine Drugs and Supplement
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Drugs and Supplement Distributors
11.3 Equine Drugs and Supplement Customer
12 WORLD FORECAST REVIEW FOR EQUINE DRUGS AND SUPPLEMENT BY GEOGRAPHIC REGION
12.1 Global Equine Drugs and Supplement Market Size Forecast by Region
12.1.1 Global Equine Drugs and Supplement Forecast by Region (2027-2032)
12.1.2 Global Equine Drugs and Supplement Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Equine Drugs and Supplement Forecast by Type (2027-2032)
12.7 Global Equine Drugs and Supplement Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer Animal Health
13.1.1 Bayer Animal Health Company Information
13.1.2 Bayer Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
13.1.3 Bayer Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer Animal Health Main Business Overview
13.1.5 Bayer Animal Health Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Equine Drugs and Supplement Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Elanco (Eli Lilly)
13.3.1 Elanco (Eli Lilly) Company Information
13.3.2 Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolios and Specifications
13.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Elanco (Eli Lilly) Main Business Overview
13.3.5 Elanco (Eli Lilly) Latest Developments
13.4 Merck Animal Health
13.4.1 Merck Animal Health Company Information
13.4.2 Merck Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
13.4.3 Merck Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Animal Health Main Business Overview
13.4.5 Merck Animal Health Latest Developments
13.5 Merial
13.5.1 Merial Company Information
13.5.2 Merial Equine Drugs and Supplement Product Portfolios and Specifications
13.5.3 Merial Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Merial Main Business Overview
13.5.5 Merial Latest Developments
13.6 Novartis Animal Health
13.6.1 Novartis Animal Health Company Information
13.6.2 Novartis Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
13.6.3 Novartis Animal Health Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Novartis Animal Health Main Business Overview
13.6.5 Novartis Animal Health Latest Developments
13.7 Zoetis
13.7.1 Zoetis Company Information
13.7.2 Zoetis Equine Drugs and Supplement Product Portfolios and Specifications
13.7.3 Zoetis Equine Drugs and Supplement Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zoetis Main Business Overview
13.7.5 Zoetis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Equine Drugs and Supplement Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Equine Drugs and Supplement Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Supplements
Table 4. Major Players of Pharmaceutical Drugs
Table 5. Global Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 6. Global Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Table 7. Global Equine Drugs and Supplement Revenue by Type (2021-2026) & ($ million)
Table 8. Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2026)
Table 9. Global Equine Drugs and Supplement Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Equine Drugs and Supplement Sale by Application (2021-2026) & (K Units)
Table 11. Global Equine Drugs and Supplement Sale Market Share by Application (2021-2026)
Table 12. Global Equine Drugs and Supplement Revenue by Application (2021-2026) & ($ million)
Table 13. Global Equine Drugs and Supplement Revenue Market Share by Application (2021-2026)
Table 14. Global Equine Drugs and Supplement Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Equine Drugs and Supplement Sales by Company (2021-2026) & (K Units)
Table 16. Global Equine Drugs and Supplement Sales Market Share by Company (2021-2026)
Table 17. Global Equine Drugs and Supplement Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Equine Drugs and Supplement Revenue Market Share by Company (2021-2026)
Table 19. Global Equine Drugs and Supplement Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Equine Drugs and Supplement Producing Area Distribution and Sales Area
Table 21. Players Equine Drugs and Supplement Products Offered
Table 22. Equine Drugs and Supplement Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Equine Drugs and Supplement Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Equine Drugs and Supplement Sales Market Share Geographic Region (2021-2026)
Table 27. Global Equine Drugs and Supplement Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Equine Drugs and Supplement Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Equine Drugs and Supplement Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Equine Drugs and Supplement Sales Market Share by Country/Region (2021-2026)
Table 31. Global Equine Drugs and Supplement Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Equine Drugs and Supplement Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Equine Drugs and Supplement Sales by Country (2021-2026) & (K Units)
Table 34. Americas Equine Drugs and Supplement Sales Market Share by Country (2021-2026)
Table 35. Americas Equine Drugs and Supplement Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 37. Americas Equine Drugs and Supplement Sales by Application (2021-2026) & (K Units)
Table 38. APAC Equine Drugs and Supplement Sales by Region (2021-2026) & (K Units)
Table 39. APAC Equine Drugs and Supplement Sales Market Share by Region (2021-2026)
Table 40. APAC Equine Drugs and Supplement Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 42. APAC Equine Drugs and Supplement Sales by Application (2021-2026) & (K Units)
Table 43. Europe Equine Drugs and Supplement Sales by Country (2021-2026) & (K Units)
Table 44. Europe Equine Drugs and Supplement Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 46. Europe Equine Drugs and Supplement Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Equine Drugs and Supplement Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Equine Drugs and Supplement Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Equine Drugs and Supplement Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Equine Drugs and Supplement
Table 52. Key Market Challenges & Risks of Equine Drugs and Supplement
Table 53. Key Industry Trends of Equine Drugs and Supplement
Table 54. Equine Drugs and Supplement Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Equine Drugs and Supplement Distributors List
Table 57. Equine Drugs and Supplement Customer List
Table 58. Global Equine Drugs and Supplement Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Equine Drugs and Supplement Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Equine Drugs and Supplement Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Equine Drugs and Supplement Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Equine Drugs and Supplement Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Equine Drugs and Supplement Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Equine Drugs and Supplement Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Equine Drugs and Supplement Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Equine Drugs and Supplement Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Equine Drugs and Supplement Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Equine Drugs and Supplement Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Equine Drugs and Supplement Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Equine Drugs and Supplement Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Equine Drugs and Supplement Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bayer Animal Health Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
Table 74. Bayer Animal Health Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bayer Animal Health Main Business
Table 76. Bayer Animal Health Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Equine Drugs and Supplement Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Elanco (Eli Lilly) Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 83. Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolios and Specifications
Table 84. Elanco (Eli Lilly) Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Elanco (Eli Lilly) Main Business
Table 86. Elanco (Eli Lilly) Latest Developments
Table 87. Merck Animal Health Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
Table 89. Merck Animal Health Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Animal Health Main Business
Table 91. Merck Animal Health Latest Developments
Table 92. Merial Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 93. Merial Equine Drugs and Supplement Product Portfolios and Specifications
Table 94. Merial Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Merial Main Business
Table 96. Merial Latest Developments
Table 97. Novartis Animal Health Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
Table 99. Novartis Animal Health Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Novartis Animal Health Main Business
Table 101. Novartis Animal Health Latest Developments
Table 102. Zoetis Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 103. Zoetis Equine Drugs and Supplement Product Portfolios and Specifications
Table 104. Zoetis Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Zoetis Main Business
Table 106. Zoetis Latest Developments
Table 1. Equine Drugs and Supplement Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Equine Drugs and Supplement Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Supplements
Table 4. Major Players of Pharmaceutical Drugs
Table 5. Global Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 6. Global Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Table 7. Global Equine Drugs and Supplement Revenue by Type (2021-2026) & ($ million)
Table 8. Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2026)
Table 9. Global Equine Drugs and Supplement Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Equine Drugs and Supplement Sale by Application (2021-2026) & (K Units)
Table 11. Global Equine Drugs and Supplement Sale Market Share by Application (2021-2026)
Table 12. Global Equine Drugs and Supplement Revenue by Application (2021-2026) & ($ million)
Table 13. Global Equine Drugs and Supplement Revenue Market Share by Application (2021-2026)
Table 14. Global Equine Drugs and Supplement Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Equine Drugs and Supplement Sales by Company (2021-2026) & (K Units)
Table 16. Global Equine Drugs and Supplement Sales Market Share by Company (2021-2026)
Table 17. Global Equine Drugs and Supplement Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Equine Drugs and Supplement Revenue Market Share by Company (2021-2026)
Table 19. Global Equine Drugs and Supplement Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Equine Drugs and Supplement Producing Area Distribution and Sales Area
Table 21. Players Equine Drugs and Supplement Products Offered
Table 22. Equine Drugs and Supplement Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Equine Drugs and Supplement Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Equine Drugs and Supplement Sales Market Share Geographic Region (2021-2026)
Table 27. Global Equine Drugs and Supplement Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Equine Drugs and Supplement Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Equine Drugs and Supplement Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Equine Drugs and Supplement Sales Market Share by Country/Region (2021-2026)
Table 31. Global Equine Drugs and Supplement Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Equine Drugs and Supplement Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Equine Drugs and Supplement Sales by Country (2021-2026) & (K Units)
Table 34. Americas Equine Drugs and Supplement Sales Market Share by Country (2021-2026)
Table 35. Americas Equine Drugs and Supplement Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 37. Americas Equine Drugs and Supplement Sales by Application (2021-2026) & (K Units)
Table 38. APAC Equine Drugs and Supplement Sales by Region (2021-2026) & (K Units)
Table 39. APAC Equine Drugs and Supplement Sales Market Share by Region (2021-2026)
Table 40. APAC Equine Drugs and Supplement Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 42. APAC Equine Drugs and Supplement Sales by Application (2021-2026) & (K Units)
Table 43. Europe Equine Drugs and Supplement Sales by Country (2021-2026) & (K Units)
Table 44. Europe Equine Drugs and Supplement Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 46. Europe Equine Drugs and Supplement Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Equine Drugs and Supplement Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Equine Drugs and Supplement Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Equine Drugs and Supplement Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Equine Drugs and Supplement Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Equine Drugs and Supplement
Table 52. Key Market Challenges & Risks of Equine Drugs and Supplement
Table 53. Key Industry Trends of Equine Drugs and Supplement
Table 54. Equine Drugs and Supplement Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Equine Drugs and Supplement Distributors List
Table 57. Equine Drugs and Supplement Customer List
Table 58. Global Equine Drugs and Supplement Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Equine Drugs and Supplement Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Equine Drugs and Supplement Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Equine Drugs and Supplement Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Equine Drugs and Supplement Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Equine Drugs and Supplement Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Equine Drugs and Supplement Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Equine Drugs and Supplement Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Equine Drugs and Supplement Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Equine Drugs and Supplement Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Equine Drugs and Supplement Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Equine Drugs and Supplement Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Equine Drugs and Supplement Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Equine Drugs and Supplement Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bayer Animal Health Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
Table 74. Bayer Animal Health Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bayer Animal Health Main Business
Table 76. Bayer Animal Health Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Equine Drugs and Supplement Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. Elanco (Eli Lilly) Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 83. Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolios and Specifications
Table 84. Elanco (Eli Lilly) Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Elanco (Eli Lilly) Main Business
Table 86. Elanco (Eli Lilly) Latest Developments
Table 87. Merck Animal Health Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
Table 89. Merck Animal Health Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Animal Health Main Business
Table 91. Merck Animal Health Latest Developments
Table 92. Merial Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 93. Merial Equine Drugs and Supplement Product Portfolios and Specifications
Table 94. Merial Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Merial Main Business
Table 96. Merial Latest Developments
Table 97. Novartis Animal Health Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Animal Health Equine Drugs and Supplement Product Portfolios and Specifications
Table 99. Novartis Animal Health Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Novartis Animal Health Main Business
Table 101. Novartis Animal Health Latest Developments
Table 102. Zoetis Basic Information, Equine Drugs and Supplement Manufacturing Base, Sales Area and Its Competitors
Table 103. Zoetis Equine Drugs and Supplement Product Portfolios and Specifications
Table 104. Zoetis Equine Drugs and Supplement Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Zoetis Main Business
Table 106. Zoetis Latest Developments
LIST OF FIGURES
Figure 1. Picture of Equine Drugs and Supplement
Figure 2. Equine Drugs and Supplement Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Drugs and Supplement Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Equine Drugs and Supplement Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Equine Drugs and Supplement Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Equine Drugs and Supplement Sales Market Share by Country/Region (2025)
Figure 10. Equine Drugs and Supplement Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Supplements
Figure 12. Product Picture of Pharmaceutical Drugs
Figure 13. Global Equine Drugs and Supplement Sales Market Share by Type in 2026
Figure 14. Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2026)
Figure 15. Equine Drugs and Supplement Consumed in Drugstores
Figure 16. Global Equine Drugs and Supplement Market: Drugstores (2021-2026) & (K Units)
Figure 17. Equine Drugs and Supplement Consumed in Veterinary Hospitals
Figure 18. Global Equine Drugs and Supplement Market: Veterinary Hospitals (2021-2026) & (K Units)
Figure 19. Equine Drugs and Supplement Consumed in Others
Figure 20. Global Equine Drugs and Supplement Market: Others (2021-2026) & (K Units)
Figure 21. Global Equine Drugs and Supplement Sale Market Share by Application (2025)
Figure 22. Global Equine Drugs and Supplement Revenue Market Share by Application in 2026
Figure 23. Equine Drugs and Supplement Sales by Company in 2026 (K Units)
Figure 24. Global Equine Drugs and Supplement Sales Market Share by Company in 2026
Figure 25. Equine Drugs and Supplement Revenue by Company in 2026 ($ millions)
Figure 26. Global Equine Drugs and Supplement Revenue Market Share by Company in 2026
Figure 27. Global Equine Drugs and Supplement Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Equine Drugs and Supplement Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Equine Drugs and Supplement Sales 2021-2026 (K Units)
Figure 30. Americas Equine Drugs and Supplement Revenue 2021-2026 ($ millions)
Figure 31. APAC Equine Drugs and Supplement Sales 2021-2026 (K Units)
Figure 32. APAC Equine Drugs and Supplement Revenue 2021-2026 ($ millions)
Figure 33. Europe Equine Drugs and Supplement Sales 2021-2026 (K Units)
Figure 34. Europe Equine Drugs and Supplement Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Equine Drugs and Supplement Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Equine Drugs and Supplement Revenue 2021-2026 ($ millions)
Figure 37. Americas Equine Drugs and Supplement Sales Market Share by Country in 2026
Figure 38. Americas Equine Drugs and Supplement Revenue Market Share by Country (2021-2026)
Figure 39. Americas Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Figure 40. Americas Equine Drugs and Supplement Sales Market Share by Application (2021-2026)
Figure 41. United States Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Equine Drugs and Supplement Sales Market Share by Region in 2026
Figure 46. APAC Equine Drugs and Supplement Revenue Market Share by Region (2021-2026)
Figure 47. APAC Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Figure 48. APAC Equine Drugs and Supplement Sales Market Share by Application (2021-2026)
Figure 49. China Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 53. India Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Equine Drugs and Supplement Sales Market Share by Country in 2026
Figure 57. Europe Equine Drugs and Supplement Revenue Market Share by Country (2021-2026)
Figure 58. Europe Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Figure 59. Europe Equine Drugs and Supplement Sales Market Share by Application (2021-2026)
Figure 60. Germany Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 61. France Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Equine Drugs and Supplement Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Equine Drugs and Supplement Sales Market Share by Application (2021-2026)
Figure 68. Egypt Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Equine Drugs and Supplement in 2026
Figure 74. Manufacturing Process Analysis of Equine Drugs and Supplement
Figure 75. Industry Chain Structure of Equine Drugs and Supplement
Figure 76. Channels of Distribution
Figure 77. Global Equine Drugs and Supplement Sales Market Forecast by Region (2027-2032)
Figure 78. Global Equine Drugs and Supplement Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Equine Drugs and Supplement Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Equine Drugs and Supplement Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Equine Drugs and Supplement Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Equine Drugs and Supplement Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Equine Drugs and Supplement
Figure 2. Equine Drugs and Supplement Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Drugs and Supplement Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Equine Drugs and Supplement Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Equine Drugs and Supplement Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Equine Drugs and Supplement Sales Market Share by Country/Region (2025)
Figure 10. Equine Drugs and Supplement Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Supplements
Figure 12. Product Picture of Pharmaceutical Drugs
Figure 13. Global Equine Drugs and Supplement Sales Market Share by Type in 2026
Figure 14. Global Equine Drugs and Supplement Revenue Market Share by Type (2021-2026)
Figure 15. Equine Drugs and Supplement Consumed in Drugstores
Figure 16. Global Equine Drugs and Supplement Market: Drugstores (2021-2026) & (K Units)
Figure 17. Equine Drugs and Supplement Consumed in Veterinary Hospitals
Figure 18. Global Equine Drugs and Supplement Market: Veterinary Hospitals (2021-2026) & (K Units)
Figure 19. Equine Drugs and Supplement Consumed in Others
Figure 20. Global Equine Drugs and Supplement Market: Others (2021-2026) & (K Units)
Figure 21. Global Equine Drugs and Supplement Sale Market Share by Application (2025)
Figure 22. Global Equine Drugs and Supplement Revenue Market Share by Application in 2026
Figure 23. Equine Drugs and Supplement Sales by Company in 2026 (K Units)
Figure 24. Global Equine Drugs and Supplement Sales Market Share by Company in 2026
Figure 25. Equine Drugs and Supplement Revenue by Company in 2026 ($ millions)
Figure 26. Global Equine Drugs and Supplement Revenue Market Share by Company in 2026
Figure 27. Global Equine Drugs and Supplement Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Equine Drugs and Supplement Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Equine Drugs and Supplement Sales 2021-2026 (K Units)
Figure 30. Americas Equine Drugs and Supplement Revenue 2021-2026 ($ millions)
Figure 31. APAC Equine Drugs and Supplement Sales 2021-2026 (K Units)
Figure 32. APAC Equine Drugs and Supplement Revenue 2021-2026 ($ millions)
Figure 33. Europe Equine Drugs and Supplement Sales 2021-2026 (K Units)
Figure 34. Europe Equine Drugs and Supplement Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Equine Drugs and Supplement Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Equine Drugs and Supplement Revenue 2021-2026 ($ millions)
Figure 37. Americas Equine Drugs and Supplement Sales Market Share by Country in 2026
Figure 38. Americas Equine Drugs and Supplement Revenue Market Share by Country (2021-2026)
Figure 39. Americas Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Figure 40. Americas Equine Drugs and Supplement Sales Market Share by Application (2021-2026)
Figure 41. United States Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Equine Drugs and Supplement Sales Market Share by Region in 2026
Figure 46. APAC Equine Drugs and Supplement Revenue Market Share by Region (2021-2026)
Figure 47. APAC Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Figure 48. APAC Equine Drugs and Supplement Sales Market Share by Application (2021-2026)
Figure 49. China Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 53. India Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Equine Drugs and Supplement Sales Market Share by Country in 2026
Figure 57. Europe Equine Drugs and Supplement Revenue Market Share by Country (2021-2026)
Figure 58. Europe Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Figure 59. Europe Equine Drugs and Supplement Sales Market Share by Application (2021-2026)
Figure 60. Germany Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 61. France Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Equine Drugs and Supplement Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Equine Drugs and Supplement Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Equine Drugs and Supplement Sales Market Share by Application (2021-2026)
Figure 68. Egypt Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Equine Drugs and Supplement Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Equine Drugs and Supplement in 2026
Figure 74. Manufacturing Process Analysis of Equine Drugs and Supplement
Figure 75. Industry Chain Structure of Equine Drugs and Supplement
Figure 76. Channels of Distribution
Figure 77. Global Equine Drugs and Supplement Sales Market Forecast by Region (2027-2032)
Figure 78. Global Equine Drugs and Supplement Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Equine Drugs and Supplement Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Equine Drugs and Supplement Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Equine Drugs and Supplement Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Equine Drugs and Supplement Revenue Market Share Forecast by Application (2027-2032)
